GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » Debt-to-Revenue

Cannabist Company Holdings (NEOE:CBST) Debt-to-Revenue : 1.12 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cannabist Company Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$29.6 Mil. Cannabist Company Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$713.5 Mil. Cannabist Company Holdings's annualized Revenue for the quarter that ended in Mar. 2024 was C$663.9 Mil. Cannabist Company Holdings's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 1.12.


Cannabist Company Holdings Debt-to-Revenue Historical Data

The historical data trend for Cannabist Company Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Debt-to-Revenue Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 1.08 1.65 0.92 1.11 1.07

Cannabist Company Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.08 1.12 1.06 1.12

Competitive Comparison of Cannabist Company Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's Debt-to-Revenue falls into.



Cannabist Company Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cannabist Company Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(30.796 + 702.152) / 685.996
=1.07

Cannabist Company Holdings's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(29.59 + 713.473) / 663.864
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Cannabist Company Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings (NEOE:CBST) Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc Formerly Columbia Care Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under Amber, ClaraCeed, Press, Platinum label, Platinum Partners, Seed & Starin, and Triple 777 brands.
Executives
Alison Worthington Director

Cannabist Company Holdings (NEOE:CBST) Headlines

No Headlines